(Q44049069)

29 November 2017

title

The role of hyperhomocysteinemia and methylenetetrahydrofolate reductase (MTHFR) C677T mutation in patients with retinal artery occlusion (English)

1 reference

29 November 2017

6

Otto Schmut

1 reference

29 November 2017

1

Martin Weger

1 reference

29 November 2017

5

Wilfried Renner

1 reference

29 November 2017

Olaf Stanger

2

1 reference

29 November 2017

Hannes Deutschmann

3

1 reference

29 November 2017

Franz Josef Leitner

4

1 reference

29 November 2017

Jürgen Semmelrock

7

1 reference

29 November 2017

Anton Haas

8

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 July 2002

1 reference

American Journal of Ophthalmology

29 November 2017

published in

1 reference

29 November 2017

volume

134

1 reference

29 November 2017

issue

1

1 reference

29 November 2017

page(s)

57-61

1 reference

Abnormalities in haemorheological factors and lipoprotein (a) in retinal vascular occlusion: implications for increased vascular risk

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901471-X

Hyperhomocysteinemia: an independent risk factor for vascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901471-X

A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901471-X

Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901471-X

Association between Plasma Homocysteine Concentrations and Extracranial Carotid-Artery Stenosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901471-X

Homocysteine and cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901471-X

Vitamins as homocysteine-lowering agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901471-X

A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901471-X

Low folate levels and thermolabile methylenetetrahydrofolate reductase as primary determinant of mild hyperhomocystinemia in normal and thromboembolic subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901471-X

The 677C-->T mutation in the methylenetetrahydrofolate reductase gene: associations with plasma total homocysteine levels and risk of coronary atherosclerotic disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901471-X

A mutation in the methylenetetrahydrofolate reductase gene is not associated with increased risk for coronary artery disease or myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901471-X

Hyperhomocystinemia in patients with nonarteritic anterior ischemic optic neuropathy, central retinal artery occlusion, and central retinal vein occlusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901471-X

Raised plasma homocysteine as a risk factor for retinal vascular occlusive disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901471-X

Thermolabile MTHFR genotype and retinal vascular occlusive disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901471-X

Evidence of altered homocysteine metabolism in chronic renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901471-X

Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901471-X

Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901471-X

The effects of folic acid supplementation on plasma total homocysteine are modulated by multivitamin use and methylenetetrahydrofolate reductase genotypes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901471-X

Acute hyperhomocysteinaemia and endothelial dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901471-X

Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901471-X

Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901471-X

Homocysteine and vascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901471-X

Homocysteine and atherothrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901471-X

Vascular dysfunction in hyperhomocyst(e)inemia. Implications for atherothrombotic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901471-X

Effect of folic acid and antioxidant vitamins on endothelial dysfunction in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901471-X

Folic acid improves arterial endothelial function in adults with hyperhomocystinemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901471-X

10.1016/S0002-9394(02)01471-X

7 January 2021

Identifiers

DOI

1 reference

29 November 2017

1 reference